PHYSICIAN NOTES: CMS Will Expand Coverage Of Abarelix For Prostate Cancer

Why This Topic Matters

The article brings together multiple Medicare policy and enforcement items that can affect reimbursement, claim processing, and compliance across oncology, psychiatry, podiatry, and orthopedics. Readers can use it to identify which coverage and payment updates may affect their practices or billing workflows.

Article Sections

1. Expanded Medicare coverage for abarelix

   Summarizes a Medicare coverage update related to treatment for advanced prostate cancer and the general patient categories addressed by the policy change.

2. Carrier coverage for Abraxane

   Describes a regional carrier policy on a breast cancer drug, including the general context for coverage and claim submission considerations.

3. Fraud sentencing in Medicare podiatry billing case

   Reports on a Medicare fraud enforcement action involving alleged improper billing and restitution.

4. HPSA payment clarification for psychiatrists

   Explains a Medicare manual clarification affecting shortage-area bonus payments and carrier handling of those claims.

5. Coverage of ultrasound stimulation for nonunion fractures

   Covers a Medicare coverage decision and review process for ultrasound stimulation treatment in fracture care.